Trial intelligence / Profile preview

Latanoprost vs Fotil in Glaucoma/OHT

NCT00304785Phase 4Completed

Sponsor
PRN Pharmaceutical Research Network
Start
May 2005
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of latanoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by PRN Pharmaceutical Research Network. Started May 2005; status: completed.

02

Drugs

latanoprost
03

Conditions

open-angle glaucoma (OAG)ocular hypertension

Beyond the preview

Go deeper on NCT00304785.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00304785.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call